Alirocumab is a medication that belongs to a class of drugs known as PCSK9 inhibitors. It is used to lower levels of LDL cholesterol, also known as “bad” cholesterol, in the blood. High levels of LDL cholesterol can increase the risk of heart disease, stroke, and other cardiovascular problems.

Alirocumab works by blocking the action of a protein called PCSK9, which plays a role in regulating the amount of LDL cholesterol in the blood. By inhibiting PCSK9, alirocumab helps the liver remove more LDL cholesterol from the bloodstream, leading to lower cholesterol levels.

This medication is typically prescribed for individuals who have not been able to lower their LDL cholesterol levels enough through diet and exercise alone, or who have a genetic condition that causes high cholesterol levels. It is usually used in combination with other cholesterol-lowering medications, such as statins.

Alirocumab is administered as an injection under the skin, usually every two weeks or once a month, depending on the dosage prescribed by your healthcare provider. It is important to follow your healthcare provider’s instructions carefully and attend all scheduled appointments to monitor your cholesterol levels and response to the medication.

As with any medication, alirocumab may cause side effects in some individuals. Common side effects may include injection site reactions, such as redness, swelling, or itching. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Overall, alirocumab is an effective and well-tolerated medication for lowering LDL cholesterol levels in individuals at risk for cardiovascular disease. If you have been prescribed alirocumab, be sure to take it as directed and follow up with your healthcare provider regularly to monitor your cholesterol levels and overall health.